https://idataresearch.com/wp-content/themes/lambda-child-theme/images/footer-logo.png
https://idataresearch.com/wp-content/themes/lambda-child-theme/images/idata-white-logo.png

Breast Reconstruction

Showing all 3 results

Soft Tissue Repair Market Analysis, Size, Trends | Europe | 2018-2024 | MedSuite | Includes: Breast Reconstruction, Hernia Repair, Dural Repair and more

Overall, the European soft tissue repair market is expected to increase at a CAGR of 1.8% to reach nearly $520 million by 2024. If there is one factor that affects nearly every segment in this report, it’s an aging population. The demographic of those over the age of 65 is increasing in Europe, which leads

more...

Soft Tissue Repair Market Size, Share & COVID-19 Impact Analysis | United States | 2022-2028 | MedSuite | Includes: Breast Reconstruction Market, Hernia Repair Market, and 4 more

In 2021, the U.S. Soft Tissue Repair Market was valued at $2.4 billion. This is expected to increase over the forecast period at a CAGR of 6.9% to reach $3.8 billion. The full report suite on the U.S. market for soft tissue repair includes breast reconstruction, hernia repair, dural repair, dental soft tissue regeneration, nerve

more...

Breast Reconstruction Market | Europe | 2018-2024 | MedCore

The total breast reconstruction market is expected to show moderate growth in upcoming years, fueled by the continuing success of biologics, especially LifeCell’s Strattice™, which has been showing substantial growth since its introduction to the European market. The outstanding clinical reviews and patient satisfaction garnered by biologic matrices will allow Strattice™ to continue to be

more...